MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition

被引:425
|
作者
Mollaoglu, Gurkan [1 ]
Guthrie, Matthew R. [1 ]
Boehm, Stefanie [2 ,3 ]
Braegelmann, Johannes [2 ,3 ]
Can, Ismail [1 ]
Ballieu, Paul M. [1 ]
Marx, Annika [2 ,3 ]
George, Julie [3 ]
Heinen, Christine [3 ]
Chalishazar, Milind D. [1 ]
Cheng, Haixia [1 ]
Ireland, Abbie S. [1 ]
Denning, Kendall E. [1 ]
Mukhopadhyay, Anandaroop [1 ]
Vahrenkamp, Jeffery M. [1 ]
Berrett, Kristofer C. [1 ]
Mosbruger, Timothy L. [4 ]
Wang, Jun [5 ]
Kohan, Jessica L. [6 ,7 ]
Salama, Mohamed E. [6 ,7 ]
Witt, Benjamin L. [6 ,7 ]
Peifer, Martin [3 ,8 ]
Thomas, Roman K. [3 ,9 ,10 ]
Gertz, Jason [1 ]
Johnson, Jane E. [11 ]
Gazdar, Adi F. [12 ]
Wechsler-Reya, Robert J.
Sos, Martin L. [2 ,3 ]
Oliver, Trudy G. [1 ]
机构
[1] Univ Utah, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT 84112 USA
[2] Univ Cologne, Inst Pathol, Fac Med, Mol Pathol, D-50937 Cologne, Germany
[3] Univ Cologne, Fac Med, Dept Translat Genom, Ctr Integrated Oncol Cologne Bonn, D-50931 Cologne, Germany
[4] Huntsman Canc Inst, Bioinformat Shared Resource, Salt Lake City, UT 84112 USA
[5] Sanford Burnham Prebys Med Discovery Inst, Tumor Initiat & Maintenance Program, La Jolla, CA 92037 USA
[6] Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA
[7] ARUP Labs, Salt Lake City, UT 84112 USA
[8] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany
[9] Univ Hosp Cologne, Dept Pathol, D-50937 Cologne, Germany
[10] German Canc Consortium DKTK, German Canc Res Ctr DKFZ, D-69120 Heidelberg, Germany
[11] Univ Texas Southwestern Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA
[12] UT Southwestern Med Ctr, Dept Pathol, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75235 USA
关键词
MOUSE MODEL; N-MYC; TUMOR; LINES; CARCINOMAS; FAMILY; GENE; IDENTIFICATION; HETEROGENEITY; AMPLIFICATION;
D O I
10.1016/j.ccell.2016.12.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Loss of the tumor suppressors RB1 and TP53 and MYC amplification are frequent oncogenic events in small cell lung cancer (SCLC). We show that Myc expression cooperates with Rb1 and Trp53 loss in the mouse lung to promote aggressive, highly metastatic tumors, that are initially sensitive to chemotherapy followed by relapse, similar to human SCLC. Importantly, MYC drives a neuroendocrine-low "variant" subset of SCLC with high NEUROD1 expression corresponding to transcriptional profiles of human SCLC. Targeted drug screening reveals that SCLC with high MYC expression is vulnerable to Aurora kinase inhibition, which, combined with chemotherapy, strongly suppresses tumor progression and increases survival. These data identify molecular features for patient stratification and uncover a potential targeted treatment approach for MYC-driven SCLC.
引用
收藏
页码:270 / 285
页数:16
相关论文
共 50 条
  • [1] Targeting mitogenic addiction as a therapeutic vulnerability in neuroendocrine subtype of small cell lung cancer
    Sen, T.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S130 - S130
  • [2] MYC Drives Temporal Evolution of Small Cell Lung Cancer Subtypes by Reprogramming Neuroendocrine Fate
    Ireland, Abbie S.
    Micinski, Alexi M.
    Kastner, David W.
    Guo, Bingqian
    Wait, Sarah J.
    Spainhower, Kyle B.
    Conley, Christopher C.
    Chen, Opal S.
    Guthrie, Matthew R.
    Soltero, Danny
    Qiao, Yi
    Huang, Xiaomeng
    Tarapcsak, Szabolcs
    Devarakonda, Siddhartha
    Chalishazar, Milind D.
    Gertz, Jason
    Moser, Justin C.
    Marth, Gabor
    Puri, Sonam
    Witt, Benjamin L.
    Spike, Benjamin T.
    Oliver, Trudy G.
    CANCER CELL, 2020, 38 (01) : 60 - +
  • [3] MYC drives temporal evolution of small cell lung cancer subtypes by reprogramming neuroendocrine fate.
    Ireland, Abbie S.
    Micinski, Alexi M.
    Kastner, David W.
    Guo, Bingqian
    Wait, Sarah J.
    Spainhower, Kyle B.
    Conley, Christopher C.
    Chen, Opal S.
    Guthrie, Matthew R.
    Soltero, Danny
    Qiao, Yi
    Huang, Xiaomeng
    Tarapcsak, Szabolcs
    Devarakonda, Siddhartha
    Chalishazar, Milind D.
    Gertz, Jason
    Moser, Justin C.
    Marth, Gabor
    Puri, Sonam
    Witt, Benjamin L.
    Spike, Benjamin T.
    Oliver, Trudy G.
    CANCER RESEARCH, 2020, 80 (21)
  • [4] Relationship Between MYC Family Status and Sensitivity to Aurora Kinase Inhibitors in Neuroendocrine and Other Lung Cancer Cell Lines
    Haruki, T.
    Papari-Zareei, M.
    Zhang, W.
    Zhang, Y.
    Stastny, V.
    Minna, J.
    Gazdar, A.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2044 - S2044
  • [5] BPR6K609: An Aurora kinase inhibitor targeting small cell lung cancer with MYC amplification
    Chi, Ya-Hui
    Chang, Chun-Ping
    Ke, Yi-Yu
    Lin, Wen-Hsing
    Wang, Wan-Ping
    Tsai, Chia-Hua
    Chen, Yen-Ting
    Su, Yu-Jie
    Hung, Ming-Chun
    Wu, Zhong-Wei
    Wu, Mine-Hsine
    Yeh, Teng-Kuang
    Chen, Ching-Ping
    Song, Jen-Shin
    Chen, Chiung-Tong
    Shih, Chuan
    CANCER RESEARCH, 2020, 80 (16)
  • [6] Relationship of Aurora-A kinase and EGFR inhibition in non-small cell lung cancer (NSCLC) cell lines
    Zhang, J.
    Pan, X.
    Astsaturov, I. A.
    Egleston, B.
    Borghaei, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [7] Determinants of Aurora kinase B inhibitor sensitivity in small cell lung cancer
    Duan, Lei
    Maki, Carl G.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (02) : 223 - 228
  • [8] AURORA-A KINASE AND EGFR INHIBITION ACT SYNERGISTICALLY IN NON-SMALL CELL LUNG CANCER (NSCLC) CELL LINES
    Pan, Xiaofan
    Zhang, Jiping
    Astsaturov, Igor
    Egelston, Brian
    Borghaei, Hossein
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S932 - S932
  • [9] Increased effect of Aurora-B kinase inhibition on endoreplicated non-small lung cancer cell lines
    Sak, A.
    Groneberg, M.
    Poettgen, C.
    Kuebler, D.
    Eberhardt, W.
    Stuschke, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 : 115 - 115
  • [10] PGC-1α drives small cell neuroendocrine cancer progression toward an ASCL1-expressing subtype with increased mitochondrial capacity
    Varuzhanyan, Grigor
    Chen, Chia-Chun
    Freeland, Jack
    He, Tian
    Tran, Wendy
    Song, Kai
    Wang, Liang
    Cheng, Donghui
    Xu, Shili
    Dibernardo, Gabriella A.
    Esedebe, Favour N.
    Bhatia, Vipul
    Han, Mingqi
    Abt, Evan R.
    Park, Jung Wook
    Memarzadeh, Sanaz
    Shackelford, David B.
    Lee, John K.
    Graeber, Thomas G.
    Shirihai, Orian S.
    Witte, Owen N.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2024, 121 (49)